The largest database of trusted experimental protocols

9 protocols using blyscan sulfated gag assay kit

1

Articular Cartilage Degradation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
According to the previously described procedures [12] (link), articular cartilages were excised from the femoral condyles of rabbit knee and incubated in DMEM containing 5% FBS for 1–2 days. In addition, approximately 30 mg cartilage fragments per well were incubated in DMEM containing 1% FBS in 400 μL/well. Cartilages were treated with 10 ng/mL of human IL-1α (Sigma–Aldrich) in the presence or absence of test compounds for 3 days. The amounts of released GAG in the supernatant were measured with a Blyscan sulfated GAG assay kit (Biocolor, Carrickfergus, County Antrim, UK) based on dimethylmethylene blue assay, according to the manufacturer's protocol.
+ Open protocol
+ Expand
2

Extracellular Matrix Composition Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression of the ECM proteins collagen I, III, IV, fibronectin, and elastin were examined by immunofluorescent staining following our previous publication [28 (link)]. The tubular constructs were opened up along the longitudinal direction. Samples were fixed, blocked, and incubated with the primary antibodies (Abcam, Cambridge, MA). After being washed, samples were incubated with secondary antibody conjugated to Alexa Fluor 488. Then the samples were mounted and viewed using an Olympus FV-1000 confocal microscope. Collagen content was quantified by a colorimetric analysis using a hydroxyproline assay kit as previously described, assuming collagen to hydroxyproline ratio is 10:1 w/w [28 (link)]. Elastin content was quantified using the Fasting Elastin Assay Kit as previously described [28 (link)]. The GAG content of the tubular constructs was determined using the Blyscan Sulfated GAG Assay Kit (Biocolor, United Kingdom) following our previously published method [28 (link)].
+ Open protocol
+ Expand
3

Chondrogenic Differentiation of Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
2 × 105 cells were placed in 15 ml polypropylene tubes and centrifuged at 1500 rpm for 10 min. The cell pellets were cultured in complete medium for 2 days. The medium was then switched to chondrogenic medium, comprised of DMEM supplemented with 1% insulin–transferrin–selenium supplement (Corning® ITS Premix, Corning Life Sciences, Bedford, MA, USA), 0.2 mM Asc-2P (Sigma–Aldrich), and 200 ng/mL recombinant human BMP2 (Osteo Pharma, Osaka, Japan) for another 21 days. The medium was replaced two times per week. For histological analysis, two pellets were fixed with 4% paraformaldehyde, embedded in paraffin, cut into 5-μm sections, and stained with Safranin O. Nuclei were counterstained with hematoxylin. For quantifying the glycosaminoglycan (GAG) content, three pellets were digested with 0.4 M papain extraction reagent overnight at 65 °C, and the GAG content was measured by Blyscan sulfated GAG assay kit (Biocolor, Carrickfergus, Ireland).
+ Open protocol
+ Expand
4

Quantifying Chondro-TEC Glycosaminoglycans

Check if the same lab product or an alternative is used in the 5 most similar protocols
To further quantify the induction of chondrogenesis, chondro-TEC were digested with 0.4 M papain extraction reagent for 3 h at 65 C, and the GAG content was quantified using a Blyscan sulfated GAG assay kit (Biocolor Ltd., Carrickfergus, UK) following the manufacture's protocol. All GAG contents are expressed as percentage of the corresponding TEC wet weights (WWs) 8, 33 .
+ Open protocol
+ Expand
5

Sulfated Glycosaminoglycan Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue pieces (~ 30–40 mg) were obtained by punch biopsy tool and dried in 60 °C oven overnight. Dried tissue pieces were digested in Papain solution at 65 °C for 18 h. Corresponding native flap tissues were dried and digested in parallel as controls. Papain (Sigma Aldrich,  ≥ 16 units/mg protein) 15–30 mg/mL stock was solubilized to working concentration of 0.1 mg/ml in 0.1 M phosphate buffer (pH 6.0), with 5 mM cysteine hydrochloride (Sigma Aldrich), and 5 mM EDTA (Sigma Aldrich). The lysates were used for detection of sulfated glycosaminoglycan (sGAG) and DNA content. The Blyscan Sulfated GAG Assay kit (Biocolor) was used to measure sGAG according to manufacturer’s instruction. Briefly, tissue specimen lysates were mixed with Blyscan Dye Reagent to bind the GAG for 1 h at room temperature. The GAG-dye complex was then collected by centrifugation at 10,000×g. After the supernatant was removed and the tube drained, Dissociation Reagent was added and 100 μl of analyte solution was transferred to a 96-well plate. Absorbance against the background control was obtained at a wavelength of 656 nm with a SpectraMax spectrophotometer (Molecular Devices). GAG amount was interpolated from a standard curve (0–5 µg) using a known GAG standard provided in the kit. Final GAG content was standardized to the total dry tissue mass (mg) used for assay.
+ Open protocol
+ Expand
6

Comprehensive Carbohydrate and Sulfate Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total carbohydrates content was determined by anthrone method, using a standard curve of glucose in the range of concentrations 0–100 μg/mL [27 ]. The hexosamine content was determined using the Ehrlich reagent method [28 (link)]. A standard curve was built using glucosamine hydrochloride in the range of concentrations 0.03–0.15 mM. Determination of uronic acids content was performed using the orcinol-based method, as previously described [29 (link)]. The standard curve was built using glucuronic acid in the range of concentrations 0.03–0.15 mM. Total protein content was determined using the Biuret method and bovine serum albumin as a standard in the range of concentrations 0–10 mg/mL. Sulfate content was estimated by barium chloride assay [30 ], using potassium sulfate in the range of 0.25–4 mg/mL to build the standard curve. All spectrophotometric analyses were carried out at a V-650 UV-VIS spectrophotometer (Jasco, Japan). The content of O- and N-sulfated GAGs and their ratio were determined using Blyscan sulfated GAG assay kit (Biocolor, UK), according to the manufacturer’s instructions. CS sodium salt from bovine trachea was used to build the standard curve. The absorbance was read at a SPECTROstar nano microplate reader (BMG Labtech, Germany). A number of six measurements was taken for each chemical analysis.
+ Open protocol
+ Expand
7

Quantification of Sulfated Glycosaminoglycans

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sGAG content in the DEWJ was measured using a Blyscan sulfated GAG assay kit (Biocolor, UK) according to the manufacturer’s instructions. Briefly, to extract sGAG, the samples were digested with a papain solution (with a concentration of 125 mg mL−1 papain in GAG buffer) (Sigma-Aldrich, USA) and placed in a water bath at 60 °C overnight. The suspension was centrifuged at 10,000g for 10 min. About 100 µL of the supernatant containing sGAG was mixed with 1 mL Blyscan dye and shaken for 30 min. The precipitate was collected by centrifugation at 12,000 rpm for 10 min and then dissolved in 1 mL of dissociation reagent. The absorbance was measured in a 96-well plate at 656 nm using a multiplate reader (H4, BIO-TEK Instruments Inc., USA).
+ Open protocol
+ Expand
8

Quantifying Glycosaminoglycans in Tissues and Urine

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue lysates were incubated with proteinase K (20 mg/mL) at a ratio of 1:10 (ProK:tissue lysate) at 55°C overnight, followed by heat inactivation of the proteinase K by boiling for 10 min. Tissue lysates were further digested with 200 units of DNase and 2 mg of RNase per 50 μL tissue lysate at room temperature overnight with gentle mixing. DNase and RNase were heat inactivated by boiling for 10 min. GAG levels were then determined using the Blyscan Sulfated GAG Assay Kit (Biocolor Life Science Assays, Cat. No. CLRB1000; Accurate Chemical, NY, Inc.) according to the manufacturer's protocol. For tissue GAGs, protein was measured using the Pierce protein assay (Cat. No. 22660; Thermo Fisher) and results were expressed as μg GAG/mg protein. For urine, GAG levels were also assessed using the Blyscan assay, normalizing to urine creatinine levels and expressed as μg GAG/mg creatinine. Creatinine levels were determined using a creatinine assay kit (MAK080; Sigma).
+ Open protocol
+ Expand
9

Decellularized Extracellular Matrix Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
To verify the extent of decellularization, histological analyses and biochemical assays were performed to evaluate the content of DNA, sGAG and collagen in the decellularized tissue. For histological evaluation, both native and decellularized tissues were fixed in paraformaldehyde, embedded in paraffin wax, sectioned at 6 ​μm with a microtome (Leica, Germany). The sections were then stained with alcian blue to access sGAG content and picro-sirius red for collagen.
For biochemical analysis, the dECM samples and native tissue were enzymatically digested with papain solution (125 ​μg/mL papain in 0.1 ​M sodium phosphate with 5 ​mM Na2-EDTA and 5 ​mM cysteine-HCl at pH 6.5) for 16 ​h at 60 ​°C. DNA content was quantified using a Quant-iT Pico Green dsDNA assay kit (Invitrogen) according to the manufacturer's protocol. Quantification of sGAG in the digested samples were performed using a dimethylmethylene blue (DMMB) assay (Blyscan sulfated GAG assay kit, Biocolor). Collagen content was indirectly quantified by measuring hydroxyproline content using a Chloramine-T assay, assuming a hydroxyproline to collagen ratio of 1:7.69 [41 ].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!